Quality of life amongst adolescents and young adults with cystic fibrosis: correlations with clinical outcomes
- PMID: 30365823
- PMCID: PMC6172978
- DOI: 10.6061/clinics/2017/e427
Quality of life amongst adolescents and young adults with cystic fibrosis: correlations with clinical outcomes
Abstract
Objectives: The current study sought to evaluate the quality of life of young patients with cystic fibrosis and correlate these results with the clinical parameters indicative of disease severity.
Methods: This cross-sectional study applied the validated Portuguese version of a cystic fibrosis specific quality of life questionnaire to clinically stable patients aged 14 to 21 years old. The correlations between the questionnaire domain scores and forced expiratory volume in one second (FEV1) values, the Shwachman-Kulczycki score, and body mass index were assessed, and correlations were considered as significant when p<0.05.
Results: A total of 31 patients (11 females; 16.4±2.3 years old) were evaluated, and the median scores on the questionnaire domains ranged from 66.7 to 100. A significant correlation was found between body mass index and the weight (r=0.43, p=0.016) and the eating questionnaire domains (r=0.44, p=0.013); between FEV1 and the physical (r=0.53, p=0.002) and treatment burden (r=0.41, p=0.023) domains; and between the Shwachman-Kulczycki score and the physical (r=0.39, p=0.03), health (r=0.41, p=0.023), and role (r=0.37, p=0.041) domains. A significant difference was found amongst patients with FEV1 values above or below 60% of the predicted value with regard to the role and health domains. No differences in the scores were found according to gender.
Conclusions: The current cystic fibrosis specific quality of life questionnaire scores exhibited wide variability across all domains; however, they indicated a relatively satisfactory quality of life amongst the patients studied. Certain domains exhibited significant correlations with clinical parameters; thus, this instrument has consistent associations with clinical outcomes.
Conflict of interest statement
No potential conflict of interest was reported.
Figures



Similar articles
-
Shwachman-Kulczycki score still useful to monitor cystic fibrosis severity.Clinics (Sao Paulo). 2011;66(6):979-83. doi: 10.1590/s1807-59322011000600010. Clinics (Sao Paulo). 2011. PMID: 21808862 Free PMC article.
-
Factors influencing quality of life and disease severity in Hungarian children and young adults with cystic fibrosis.Ital J Pediatr. 2014 Jun 2;40:50. doi: 10.1186/1824-7288-40-50. Ital J Pediatr. 2014. PMID: 24887479 Free PMC article.
-
Quality of life in cystic fibrosis: the impact of gender, general health perceptions and disease severity.J Cyst Fibros. 2003 Dec;2(4):206-13. doi: 10.1016/S1569-1993(03)00093-6. J Cyst Fibros. 2003. PMID: 15463875
-
Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection.Chest. 2009 Jun;135(6):1610-1618. doi: 10.1378/chest.08-1190. Epub 2009 May 15. Chest. 2009. PMID: 19447923 Free PMC article. Review.
-
Inhaled mannitol for cystic fibrosis.Cochrane Database Syst Rev. 2020 May 1;5(5):CD008649. doi: 10.1002/14651858.CD008649.pub4. Cochrane Database Syst Rev. 2020. PMID: 32358807 Free PMC article.
Cited by
-
The Validity and Reliability of the Turkish Version of the AWESCORE Test.Turk Arch Pediatr. 2025 Mar 3;60(2):147-152. doi: 10.5152/TurkArchPediatr.2025.24199. Turk Arch Pediatr. 2025. PMID: 40091631 Free PMC article.
-
Acceptability of patient reported outcome measures (PROMs) in a cystic fibrosis data registry.BMJ Open Respir Res. 2021 Jul;8(1):e000927. doi: 10.1136/bmjresp-2021-000927. BMJ Open Respir Res. 2021. PMID: 34281916 Free PMC article.
-
A systematic review of patient-reported outcome measures (PROMs) in cystic fibrosis.BMJ Open. 2020 Oct 1;10(10):e033867. doi: 10.1136/bmjopen-2019-033867. BMJ Open. 2020. PMID: 33004381 Free PMC article.
-
Tools used to measure quality of life in adults with cystic fibrosis- a systematic review.Health Qual Life Outcomes. 2025 Feb 4;23(1):10. doi: 10.1186/s12955-025-02338-2. Health Qual Life Outcomes. 2025. PMID: 39901267 Free PMC article.
-
Correspondence between lung function and symptom measures from the Cystic Fibrosis Respiratory Symptom Diary-Chronic Respiratory Infection Symptom Score (CFRSD-CRISS).J Cyst Fibros. 2019 Nov;18(6):886-893. doi: 10.1016/j.jcf.2019.05.009. Epub 2019 May 22. J Cyst Fibros. 2019. PMID: 31126901 Free PMC article.
References
-
- Cystic Fibrosis Foundation Patient Registry, 2015 . Annual Data Report. Bethesda, Maryland: Cystic Fibrosis Foundation; 2016.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical